ATRA Atara Biotherapeutics
- 0.700
- +0.000+0.03%
Atara Biotherapeutics News
Atara Biotherapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fust Matthew K
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director HEIDEN WILLIAM K
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Roncarolo Maria Grazia
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gallagher Carol Giltner
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director MALLIK AMEET
Atara Biotherapeutics | 8-K: Current report
Atara Biotherapeutics | 10-K: Annual report
Atara Biotherapeutics | 8-K: Atara Biotherapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Operational Progress
Atara Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%), etc.
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Touchon Pascal
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Nguyen AnhCo
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murugan Amar
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hyllengren Eric J
Atara Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henrich Jill
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Atara Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
